必治妥施貴寶公司
(BMY)

  • 股價
    50.52
  • 漲跌
    -1.14
  • 漲幅
    -2.21%
  • 成交量
    38.1萬
YahooFinanceBusiness
(Bloomberg) -- US corporate investment-grade bond sales are set to surpass $60 billion for the first time in nearly two years, propelled by a rare Friday offering from 3M Co. healthcare unit Solventum Corp.
Most Read from Bloomberg
Nvidia Rises Most in About Nine Months as AI Drives Sales
US Unv
    YahooFinanceBusiness
    If you have $5,000 you can afford to invest, that can be a good amount to put into the stock market. It can allow you to spread out your investment across multiple stocks while also giving you a decent amount of skin in the game to ensure you can earn a good return if valuations rise. And regardles
      YahooFinanceBusiness
      In this article, we discuss 16 best income stocks to buy according to analysts. You can skip our detailed analysis of income-generating stocks and their performance over the years, and go directly to read 5 Best Income Stocks To Buy According to Analysts. 
      Dividends have played a significant role 
        YahooFinanceBusiness
        The yearly results for Bristol-Myers Squibb Company (NYSE:BMY) were released last week, making it a good time to revisit its performance. The result was positive overall - although revenues of US$45b were in line with what the analysts predicted, Bristol-Myers Squibb surprised by delivering a statu
          YahooFinanceBusiness
          In this article, we will be taking a look at the 15 best hospitals for cancer treatment in the US. If you are not interested in reading about the global cancer care market, head straight to the 5 Best Hospitals For Cancer Treatment In The US.
          When battling cancer, choosing the right hospital for t
            百時美施貴寶(Bristol Myers Squibb)今天宣布,美國FDA已接受其藥品Augtyro(repotrectinib)的補充新藥申請(sNDA),用于治療12歲及以上局部晚期或轉移性成人和兒童實體瘤患者,這些患者腫瘤為神經營養性酪氨酸受體激酶(NTRK)基因融合陽性。美...
              YahooFinanceBusiness
              Genmab AS (NASDAQ:GMAB) is one of the largest Danish pharmaceutical companies focused on developing medicines to treat patients with cancer, multiple sclerosis, thyroid eye disease and various autoimmune diseases.
              Genmab has an extensive portfolio of both Food and Drug Administration-approved and 
                YahooFinanceBusiness
                Finding stocks that trade at low valuations is fairly easy as there are many companies with weak prospects trading at low valuations. However, many of those companies are cheap for a reason and lack a catalyst to drive a valuation re-rating.
                Pfizer Inc. (NYSE:PFE) is a cheap stock based on most co